Does the Oxford HELP® Pillow improve face mask ventilation and laryngoscopic view in obese patients?

2020 ◽  
Vol 30 ◽  
pp. e177-e178
Author(s):  
Xavier Onrubia ◽  
Miss. Sara Cuenca Tello ◽  
Carlos Manuel Asencio Sánchez ◽  
Victor Silvestre Vicedo ◽  
Jose Manuel Castillo Montesinos
2021 ◽  
Vol 87 (1) ◽  
Author(s):  
Amedeo BIANCHINI ◽  
Ludovica NARDOZI ◽  
Elena NARDI ◽  
Maria F. SCUPPA
Keyword(s):  

2013 ◽  
Vol 44 (5) ◽  
pp. 1028-1033 ◽  
Author(s):  
Danielle Hart ◽  
Robert Reardon ◽  
Christopher Ward ◽  
James Miner
Keyword(s):  

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e025909 ◽  
Author(s):  
Mickael Vourc’h ◽  
Donatien Huard ◽  
Fanny Feuillet ◽  
Gabrielle Baud ◽  
Arthur Guichoux ◽  
...  

IntroductionAlthough preoxygenation and airway management respond to precise algorithms, difficult intubation (DI) remains a daily challenge in intensive care units and in the operating rooms because of its frequent complications, including hypoxaemia. To prevent desaturation during DI, high-flow oxygenation by nasal cannula (HFNC) could prove beneficial. Indeed, contrary to standard preoxygenation device, it can be held in place throughout the intubation trying to perform apnoeic oxygenation during DI. Hence, recent guidelines recommend HFNC during DI, but its relevance has never been evaluated in this setting in a large randomised study until now.Methods and analysisThe PREOPTIDAM trial is a prospective, single-centre, randomised, controlled study in Nantes University Hospital. In anticipated DI, we hypothesised that HFNC can decrease the incidence of desaturation ≤94% or face mask ventilation from 16% to 4% compared with standard device. Using a two-sided t-test with a first species risk of 5% and 80% power, a total of 186 patients will be included. Using a computer-generated randomisation, with a 1:1 allocation ratio, patients will be randomised to HFNC or face mask preoxygenation. Randomisation will be stratified on intubation sequence: Rapid sequence intubation or awake fibreoptic intubation. The primary objective is to determine whether HFNC is more efficient than standard oxygenation techniques to prevent desaturation ≤94% or face mask ventilation during DI. Intent-to-treat and per-protocol analysis are planned for the primary outcome.Ethics and disseminationThe study project has been approved by an independent ethics committee. Written informed consent will be obtained before study inclusion. Participant recruitment begins in September 2018. Results will be submitted to international peer-reviewed medical journals.Trial registration numberNCT03604120.


Sign in / Sign up

Export Citation Format

Share Document